A biotech startup engaged in the research and commercialization of new materials. In addition to planning and developing over 200 CBD products, they were the first in the industry to succeed in researching nano-CBD formulations that dramatically increase CBD absorption efficiency. In May 2022, they raised approximately 150 million JPY in a Series A funding round. They already distribute CBD products to over 500 stores nationwide, including medical institutions.

FACT BOX

  • Source: PR TIMES
  • Category: キャンペーン
  • Products / services: fuwari